Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The synergistic effect of EMT regulators and m6A modification on prognosis-related immunological signatures for ovarian cancer. | Sci Rep | 2023 | 37684273 | PubTator, text mining | PubMed |
| Effects of Gestational Arsenic Exposures on Placental and Fetal Development in Mice: The Role of Cyr61 m6A. | Environ Health Perspect | 2023 | 37682722 | PubTator, text mining | PubMed |
| Changes in m6A RNA methylation of goat lung following PPRV infection. | Heliyon | 2023 | 37681172 | PubTator, text mining | PubMed |
| METTL3-mediated m6 A modification of circPRKAR1B promotes Crohn's colitis by inducing pyroptosis via autophagy inhibition. | Clin Transl Med | 2023 | 37679886 | PubTator, text mining | PubMed |
| Human aortic smooth muscle cell regulation by METTL3 via upregulation of m6A NOTCH1 modification and inhibition of NOTCH1. | Ann Transl Med | 2023 | 37675298 | PubTator, text mining | PubMed |
| Dissecting the effects of METTL3 on alternative splicing in prostate cancer. | Front Oncol | 2023 | 37675218 | PubTator, text mining | PubMed |
| Ghost authors revealed: The structure and function of human N6 -methyladenosine RNA methyltransferases. | Wiley Interdiscip Rev RNA | 2023 | 37674370 | PubTator, text mining | PubMed |
| METTL16 controls Kaposi's sarcoma-associated herpesvirus replication by regulating S-adenosylmethionine cycle. | Cell Death Dis | 2023 | 37673880 | PubTator, text mining | PubMed |
| Emerging role of METTL3 in inflammatory diseases: mechanisms and therapeutic applications. | Front Immunol | 2023 | 37671161 | PubTator, text mining | PubMed |
| N6 -methyladenosine-modified circFUT8 competitively interacts with YTHDF2 and miR-186-5p to stabilize FUT8 mRNA to promote malignant progression in lung adenocarcinoma. | Thorac Cancer | 2023 | 37669906 | PubTator, text mining | PubMed |
| The roles and therapeutic implications of messenger RNA internal N7 -methylguanosine and N6 -methyladenosine modifications in chemoresistance. | Clin Transl Med | 2023 | 37667528 | PubTator, text mining | PubMed |
| Immunological characterization and diagnostic models of RNA N6-methyladenosine regulators in Alzheimer's disease. | Sci Rep | 2023 | 37666846 | PubTator, text mining | PubMed |
| Progesterone receptor membrane component 2 is critical for human placental extravillous trophoblast invasion. | Biol Reprod | 2023 | 37665239 | PubTator, text mining | PubMed |
| RNA N6-methyladenosine reader IGF2BP3 promotes acute myeloid leukemia progression by controlling stabilization of EPOR mRNA. | PeerJ | 2023 | 37663284 | PubTator, text mining | PubMed |
| RNA methylation-driven assembly of fluorescence-encoded nanostructures for sensitive detection of m6A modification writer METTL3/14 complex in human breast tissues. | Biosens Bioelectron | 2023 | 37660462 | PubTator, text mining | PubMed |
METTL3-stabilized super enhancers-lncRNA SUCLG2-AS1 mediates the formation of a long-range chromatin loop between enhancers and promoters of SOX2 in metastasis and radiosensitivity of nasopharyngeal carcinoma. | Clin Transl Med | 2023 | 37658588 | PubTator, text mining | PubMed |
| METTL3-induced lncRNA GBAP1 promotes hepatocellular carcinoma progression by activating BMP/SMAD pathway. | Biol Direct | 2023 | 37658413 | PubTator, text mining | PubMed |
| IGF2BP3 promotes the progression of colorectal cancer and mediates cetuximab resistance by stabilizing EGFR mRNA in an m6A-dependent manner. | Cell Death Dis | 2023 | 37658049 | PubTator, text mining | PubMed |
| Towards understandings of serine/arginine-rich splicing factors. | Acta Pharm Sin B | 2023 | 37655328 | PubTator, text mining | PubMed |
| Editorial: Unveiling the tumor microenvironment by machine learning to develop new immunotherapeutic strategies. | Front Immunol | 2023 | 37654480 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=45